Search clinical trials for: YM150
Total 26 results
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetics of YM150Japan
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of YM150Japan
-
Astellas Pharma IncCompletedHealthy Volunteer | Pharmacokinetics of YM150Japan
-
Astellas Pharma IncCompletedHealthy Elderly Subject | Pharmacokinetic of YM150Japan
-
Astellas Pharma Europe B.V.CompletedAcute Coronary SyndromePoland, Colombia, Germany, Korea, Republic of, South Africa, Czech Republic, Netherlands, Hungary, Russian Federation, Mexico, Romania, Argentina, Ukraine, Denmark, Slovakia, Belgium, India, Brazil, Australia, Canada, France
-
Astellas Pharma Europe B.V.CompletedHealthy Subjects | Pharmacokinetics | Pharmacodynamics | Japanese | CaucasianGermany
-
Astellas Pharma IncCompletedThromboembolismSingapore, Indonesia, Japan, Korea, Republic of, Malaysia, Philippines, Taiwan, Thailand
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacodynamic and Pharmacokinetic InteractionFrance
-
Astellas Pharma IncCompletedAtrial FibrillationGermany, Korea, Republic of, Australia, Poland, United Kingdom, Japan, South Africa, Russian Federation, Austria, Estonia, Thailand, Bulgaria, France, Spain, Ukraine, India, Israel, Hungary, Slovakia, Malaysia, Philippines, Czech... and more
-
Astellas Pharma IncCompletedVenous ThromboembolismJapan
-
Astellas Pharma Europe B.V.CompletedVenous Thromboembolism | Arthroplasty, Replacement, HipDenmark, Spain, United States, Austria, Colombia, Russian Federation, India, Italy, United Kingdom, Germany, Hungary, Estonia, Romania, South Africa, Israel, Poland, Sweden, Canada, Australia, Lithuania, Ukraine, Latvia, Finland, Brazil, Slovak... and more
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics of Darexaban and MetabolitesFrance
-
Astellas Pharma IncAstellas Pharma Europe B.V.CompletedThromboembolismItaly, Spain, Sweden, Austria, Denmark, Russian Federation, Poland, Bosnia and Herzegovina, Serbia, Norway, Latvia, Finland, Lithuania, Czech Republic, Germany, Slovakia, Greece
-
Astellas Pharma IncCompletedHealthy | Pharmacokinetic of DigoxinFrance
-
Astellas Pharma IncCompletedVenous ThromboembolismJapan, Taiwan, Thailand
-
Astellas Pharma IncCompletedVenous ThromboembolismJapan
-
Astellas Pharma Europe B.V.CompletedA Study to Find Out How YM150 is Absorbed Into and Eliminated From the Body in Healthy Male SubjectsHealthy Male Subjects | PharmacokineticsNetherlands
-
Gilead SciencesWithdrawnDiffuse Large B-cell Lymphoma | NHL | Non Hodgkin's Lymphoma | Aggressive NHLUnited States
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacokinetics of Darexaban and MetabolitesFrance
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacodynamic InteractionFrance
-
Astellas Pharma IncCompletedArthroplasty, Replacement, KneeUnited States, Canada
-
Astellas Pharma IncCompletedHealthy Subjects | Pharmacodynamic InteractionFrance
-
Astellas Pharma IncCompletedAtrial FibrillationTaiwan, Japan, Korea, Republic of, New Zealand, Singapore, South Africa, Thailand, Australia, Hong Kong, Malaysia
-
Astellas Pharma IncCompleted
-
Astellas Pharma IncCompletedVenous ThromboembolismJapan
-
Astellas Pharma IncCompletedVenous ThromboembolismJapan, Korea, Republic of, Taiwan, Thailand